首页/数据集/Humoral and cellular immune responses following Omicron BA.2.2 breakthrough infection and Omicron BA.5 reinfection

Humoral and cellular immune responses following Omicron BA.2.2 breakthrough infection and Omicron BA.5 reinfection

NCATS Open Data2024-08-16 更新2026-08-08 收录

Omicron变异株免疫应答

突破性感染免疫

数据链接：

https://doi.org/10.1016/j.isci.2024.110283 数据链接链接失效反馈

官方服务：

资源简介：

Humoral and cellular immune responses following Omicron BA.2.2 breakthrough infection and Omicron BA.5 reinfection

应用场景：

创建时间：

2024-07-19

突破性感染免疫

新冠病毒

BackgroundResults showing that sera from double vaccinated individuals have minimal neutralizing activity against Omicron have been interpreted as indicating the need for a third vaccine dose for prot

NIAID Data Ecosystem50

Study on SARS-CoV-2 breaktrough infections at University Hospital Essen. vaccination-breakthrough

突破性感染免疫

冠状病毒免疫反应

Background: Breakthrough infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) are increasingly observed in vaccinated individuals. We investigated th

NIAID Data Ecosystem40

Prior vaccination enhances immune responses during SARS-CoV-2 breakthrough infection with early activation of memory T cells followed by production of potent neutralizing antibodies

疫苗免疫应答

突破性感染免疫

Prior vaccination enhances immune responses during SARS-CoV-2 breakthrough infection with early activation of memory T cells followed by production of potent neutralizing antibodies

NCATS Open Data2023-02-17 更新20

Table_2_Third SARS-CoV-2 vaccination and breakthrough infections enhance humoral and cellular immunity against variants of concern.pdf

免疫反应

突破性感染免疫

IntroductionSARS-CoV-2 vaccination is the leading strategy to prevent severe courses after SARS-CoV-2 infection. In our study, we analyzed humoral and cellular immune responses in detail to three cons

NIAID Data Ecosystem40

DataSheet_1_Low humoral and cellular immune responses early after breakthrough infection may contribute to severe COVID-19.docx

突破性感染免疫

COVID-19疫苗

BackgroundLittle is known about the immune determinants for severe coronavirus disease 2019 (COVID-19) in individuals vaccinated against severe acute respiratory syndrome coronavirus 2. We therefore a

NIAID Data Ecosystem30

Humoral and cellular immune responses following Omicron BA.2.2 breakthrough infection and Omicron BA.5 reinfection

资源简介：

相关数据集